Abstract
Osteoarthritis is a leading cause of chronic pain and disability affecting millions of adults who are middle-aged and older adults worldwide. 1 , 2 To determine the global, regional, and national burden of osteoarthritis, Jaimie Steinmetz and colleagues 3 estimated the prevalence and burden of hand, hip, knee, and other sites of osteoarthritis in 204 countries and territories from 1990 to 2020. They adopted statistical approaches to account for heterogenous non-reference data, added estimates for hand and other osteoarthritis sites, identified high BMI as a risk factor for lower limb osteoarthritis, and forecasted the prevalence of various types of osteoarthritis through to 2050. Their work can help numerous governments and research institutions set priorities in health policies and research to develop cost-effective prevention and treatment strategies to alleviate the burden of osteoarthritis. Although this report provides valuable data for various stakeholders to understand the regional osteoarthritis-related burden, and changes in prevalence or risk factors over time, 4 there are some inherent limitations of the Global Burden of Disease (GBD) 5 and the findings should be interpreted with caution.
Original language | English |
---|---|
Pages (from-to) | e496-e497 |
Journal | The Lancet Rheumatology |
Volume | 5 |
Issue number | 9 |
DOIs |
|
Publication status | Published - Sept 2023 |
Keywords
- Osteoarthritis
- global burden of disease
- GBD
- limitations
ASJC Scopus subject areas
- Rheumatology
- Immunology and Allergy
- Immunology